Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.078 SEK | +10.11% | +10.22% | +56.46% |
Business Summary
Number of employees: 55
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antibody-based Medicines
100.0
%
| 36 | 100.0 % | 58 | 100.0 % | +62.78% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Finland
100.0
%
| 36 | 100.0 % | 58 | 100.0 % | +62.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Søren Bregenholt
CEO | Chief Executive Officer | 53 | 21-05-31 |
Marie Svensson
DFI | Director of Finance/CFO | 60 | 20-08-31 |
Chief Tech/Sci/R&D Officer | 56 | 22-01-31 | |
Peter Ellmark
CTO | Chief Tech/Sci/R&D Officer | 51 | 17-12-31 |
Chief Tech/Sci/R&D Officer | 42 | 13-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 70 | 16-12-31 | |
Staffan Encrantz
BRD | Director/Board Member | 72 | 22-05-08 |
Director/Board Member | 62 | 21-05-31 | |
Denise Goode
BRD | Director/Board Member | 66 | 22-05-08 |
Director/Board Member | 53 | 21-05-31 | |
Chief Tech/Sci/R&D Officer | 42 | 13-12-31 | |
62 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 949,850 | 0 | 0 | 59.28 % |
Stock B | 1 | 657,954,290 | 390,619,939 ( 59.37 %) | 0 |
Company contact information
Alligator Bioscience AB
Medicon Village Scheelevägen 2
223 81, Lund
+46 4 65 40 82 00
http://www.alligatorbioscience.comGroup companies
Name | Category and Sector |
---|---|
A Bioscience Incentive AB
|
Sector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+56.46% | 77.57M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- ATORX Stock
- Company Alligator Bioscience AB